Replies to post #3527 on Kedem Pharmaceuticals, Inc.(fka KDMP)

[zorro77]

Dr.Salari Hassan holds an international patient on X-Excite & once it is approved by the EU or the FDA, the EU should be first, his patient will protect his interest & this stock will skyrocket.

[zorro77]

GHLV recently filed a new patent under the Patent Corporation Treaty program on its sublingual drug delivery technology. Under the Patent Corporation Treaty rule, a patented discovery can be protected in over 80 countries, including China and the United States. The patent, which is entitled "Method of delivering a pharmaceutical composition sublin-gually", is a new proprietary formulation. The formulation is designed to deliver small molecules such as life style drugs to larger macromolecules rapidly to the blood avoiding gastric and hepatic breakdown.